We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Pan American Health Organisation (PAHO) reports 
that the Brazilian yellow fever outbreak is continuing. Transmission of infection is not increasing but remains stable.
From December 2016 to 18 May 2017, there have been 3 192 suspected cases of yellow fever in Brazil: 758 confirmed, 1 812 discarded and 622 still under investigation. Among these cases there have been 426 deaths. Case fatality rate (CFR) in confirmed cases is 34%.
Confirmed cases have been identified in 7 states: Espírito Santo, Goiás, Minas Gerais, Pará, Rio de Janeiro, São Paulo, and Tocantins.
Yellow fever vaccine should be considered for travellers at risk.
A traveller's risk of yellow fever is determined by their general risk assessment e.g. country visited, length of stay, city or rural, activities etc. Travellers with contraindications for yellow fever vaccine (e.g. children < 9 months, pregnant or breastfeeding women, people with severe egg antigen hypersensitivity, severe immunodeficiency) or over 60 years of age are advised to seek expert assessment to help weigh up risks and benefits of vaccination.
Mosquito bite avoidance rules should be adhered to - the mosquito that spreads yellow fever bites predominantly during the day.
